Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,101 | 64 | 64.3% |
| Education | $611.90 | 8 | 35.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,179 | 53 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $218.60 | 2 | $0 (2022) |
| Arcutis Biotherapeutics, Inc. | $80.18 | 5 | $0 (2024) |
| AbbVie Inc. | $73.14 | 5 | $0 (2021) |
| PruGen, Inc. Pharmaceuticals | $69.00 | 1 | $0 (2017) |
| PFIZER INC. | $51.84 | 3 | $0 (2018) |
| Celgene Corporation | $41.03 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $273.14 | 10 | Janssen Biotech, Inc. ($192.96) |
| 2023 | $82.95 | 1 | Janssen Biotech, Inc. ($82.95) |
| 2022 | $297.39 | 19 | Janssen Biotech, Inc. ($203.79) |
| 2021 | $372.18 | 19 | Janssen Biotech, Inc. ($359.73) |
| 2020 | $24.14 | 2 | Janssen Biotech, Inc. ($24.14) |
| 2019 | $188.77 | 4 | Janssen Biotech, Inc. ($188.77) |
| 2018 | $268.97 | 10 | Regeneron Healthcare Solutions, Inc. ($125.00) |
| 2017 | $205.60 | 7 | PruGen, Inc. Pharmaceuticals ($69.00) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.27 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Dermatology | ||||||
| 09/27/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Dermatology | ||||||
| 09/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: Immunology | ||||||
| 08/01/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Dermatology | ||||||
| 07/09/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Dermatology | ||||||
| 03/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $68.99 | General |
| Category: Immunology | ||||||
| 10/02/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $82.95 | General |
| Category: Immunology | ||||||
| 08/01/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Immunology | ||||||
| 07/18/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Immunology | ||||||
| 07/07/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Immunology | ||||||
| 06/30/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: Immunology | ||||||
| 06/23/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $7.84 | General |
| Category: Immunology | ||||||
| 06/02/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Immunology | ||||||
| 05/19/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Immunology | ||||||
| 05/12/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Immunology | ||||||
| 05/05/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Immunology | ||||||
| 04/28/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: Immunology | ||||||
| 04/27/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Immunology | ||||||
| 04/14/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Immunology | ||||||
| 04/07/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Immunology | ||||||
| 04/05/2022 | Regeneron Healthcare Solutions, Inc. | — | Food and Beverage | In-kind items and services | $93.60 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 430 | 679 | $103,055 | $56,135 |
| 2022 | 10 | 406 | 616 | $92,955 | $51,818 |
| 2021 | 12 | 537 | 940 | $129,330 | $73,110 |
| 2020 | 11 | 444 | 670 | $95,268 | $47,934 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 274 | $41,120 | $22,143 | 53.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 91 | $16,380 | $10,509 | 64.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 67 | 67 | $11,620 | $6,791 | 58.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 54 | 57 | $11,400 | $5,327 | 46.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 27 | 40 | $8,400 | $4,035 | 48.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,000 | $2,355 | 58.9% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 12 | 28 | $3,920 | $1,749 | 44.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 24 | $1,920 | $1,264 | 65.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 13 | 24 | $2,880 | $1,153 | 40.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 11 | 15 | $1,200 | $773.25 | 64.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 20 | 43 | $215.00 | $35.67 | 16.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 204 | $30,600 | $16,782 | 54.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 97 | $17,460 | $11,144 | 63.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 72 | 72 | $12,240 | $7,167 | 58.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 43 | 53 | $10,600 | $5,160 | 48.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 22 | 33 | $6,930 | $3,327 | 48.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $4,250 | $2,589 | 60.9% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2022 | 18 | 38 | $5,320 | $2,584 | 48.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 32 | $2,560 | $1,763 | 68.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 11 | 23 | $2,760 | $1,259 | 45.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 22 | 47 | $235.00 | $42.75 | 18.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 100 | 173 | $31,140 | $20,643 | 66.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 126 | 217 | $32,550 | $18,556 | 57.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 69 | 78 | $15,600 | $7,690 | 49.3% |
| 11901 | Injection of more than 7 skin growths | Office | 2021 | 22 | 86 | $12,040 | $5,814 | 48.3% |
About Dr. Michael Berry, MD
Dr. Michael Berry, MD is a Dermatology healthcare provider based in Elmhurst, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1962692152.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Berry, MD has received a total of $1,713 in payments from pharmaceutical and medical device companies, with $273.14 received in 2024. These payments were reported across 72 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,101).
As a Medicare-enrolled provider, Berry has provided services to 1,817 Medicare beneficiaries, totaling 2,905 services with total Medicare billing of $228,998. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Elmhurst, NY
- Active Since 07/25/2007
- Last Updated 11/10/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962692152
Products in Payments
- TREMFYA (Drug) $834.31
- Tremfya (Drug) $239.62
- DUPIXENT DUPILUMAB INJECTION (Biological) $125.00
- Zoryve (Drug) $80.18
- Humira (Biological) $60.69
- STELARA (Biological) $56.99
- EUCRISA (Drug) $51.84
- REMICADE (Biological) $48.43
- HUMIRA (Biological) $12.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Elmhurst
Huachen Wei, Md, MD
Dermatology — Payments: $311,988
Dr. Julia Wu, Md, MD
Dermatology — Payments: $37,132
Marie Leger, Md, MD
Dermatology — Payments: $36,243
Todd Davis, Md, MD
Dermatology — Payments: $11,719
Gary Barsky, Md, MD
Dermatology — Payments: $7,310
Dr. Nikki Kim, Md, MD
Dermatology — Payments: $6,104